Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Impact of baseline PD-L1 status in BCG naive nonmuscle invasive bladder cancer on outcomes and changes after BCG exposure

Urologic Oncology Seminars and Original Investigations(2025)10.1016/j.urolonc.2025.01.015Source: DataRank Database

Impact of baseline PD-L1 status in BCG naive nonmuscle invasive bladder cancer on outcomes and changes after BCG exposure is a research paper published in Urologic Oncology Seminars and Original Investigations (2025). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

6 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 6.17)OA: closedTopics (44)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Solomon L. Woldu ORCID,Daniel Halstuch ORCID,Yaara Ber ORCID,Karin Lifshitz ORCID,Grayden Cook

Live enrichment

PubMed:39956691 OpenAlex:https://openalex.org/W4407599090

National Institutes of Health

Grant: P30CA142543

FWCI

6.17

Citation Percentile

1.0%

Influential Citations

Citation Trend

2025

2026

closedLicense: https://doi.org/10.15223/policy-004

publisherhttps://api.elsevier.com/content/article/PII:S1078143925000146?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1078143925000146?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.urolonc.2025.01.015

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39956691

Fields of Study

Bladder and Urothelial Cancer TreatmentsImmune responses and vaccinationsCancer Immunotherapy and BiomarkersMedicineHumansUrinary Bladder NeoplasmsB7-H1 AntigenBCG VaccineMaleFemaleRetrospective StudiesAgedMiddle AgedNeoplasm InvasivenessTreatment OutcomeAged, 80 and overAdjuvants, ImmunologicBiomarkers, Tumor

MeSH Terms

Adjuvants, ImmunologicAgedAged, 80 and overBCG VaccineUrinary Bladder NeoplasmsFemaleHumansMaleMiddle AgedNeoplasm InvasivenessRetrospective StudiesBiomarkers, TumorTreatment OutcomeB7-H1 Antigen

Keywords

MedicineBladder cancerOncologyInternal medicineBCG vaccineCancerUrologyTuberculosisPathologyBCGBiomarkerPD-L1

Impact of baseline PD-L1 status in BCG naive nonmuscle invasive bladder cancer on outcomes and changes after BCG exposure

FAIR Checklist

Authors (10)

Funding (1 grants)

Impact

Open Access

Topics